|
Delay Times and Clinical Outcomes in Acute Myocardial Infarction: Comparison of Periods before and during the COVID-19 Pandemic
|
Abstract:
Introduction: At the beginning of the COVID-19 pandemic, a drop in the number of patients treated for cardiac emergencies raised concern about cardiovascular mortality in that period. An increase in care delay for patients with ST-segment elevation myocardial infarction (STEMI) may have affected clinical outcomes. Objectives: To analyze delay times and clinical outcomes of patients with STEMI undergoing primary percutaneous coronary intervention (PPCI), before and during the COVID-19 pandemic. Methods: Retrospective observational study that included patients with STEMI undergoing PPCI from December 2018 to July 2021. The COVID-19 pandemic cases were divided into two groups: pandemic I—from March to August 2020; and pandemic II—from September 2020 to July 2021. Patients were compared according to the period of hospitalization. Primary outcomes were delay times in assistance and clinical outcomes (acute kidney injury [AKI], post-procedural vascular complications and in-hospital mortality). Results: 108 patients were included, 39 (36.1%) in the pre-pandemic period, 13 (12.1%) in pandemic I and 56 (51.8%) in pandemic II. Time from onset of symptoms to arrival at the service and door-to-balloon time did not differ significantly among groups. Vascular complications were more frequent during the pandemic (I and II) than in the pre-pandemic period (2.5% pre-pandemic vs 15.4% pandemic vs 12.5% pandemic II; p = 0.03). AKI incidence was similar in all three periods. There was a non-significant increase in in-hospital mortality during the COVID-19 pandemic. Conclusion: In patients with STEMI, there was an increase in vascular complications and a trend toward increased mortality during the COVID-19 pandemic. Delay times to admission and reperfusion did not differ significantly between before and during the pandemic.
[1] | Piegas, L., Timerman, A., Feitosa, G., Nicolau, J., Mattos, L., Andrade, M., et al. (2015) V Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do Miocárdio com Supradesnível do Segmento ST. Arquivos Brasileiros de Cardiologia, 105, 1-105. https://doi.org/10.5935/abc.20150107 |
[2] | Mafham, M.M., Spata, E., Goldacre, R., Gair, D., Curnow, P., Bray, M., et al. (2020) COVID-19 Pandemic and Admission Rates for and Management of Acute Coronary Syndromes in England. The Lancet, 396, 381-389. https://doi.org/10.1016/s0140-6736(20)31356-8 |
[3] | Ibanez, B., James, S., Agewall, S., Antunes, M.J., Bucciarelli-Ducci, C., Bueno, H., et al. (2017) 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation. European Heart Journal, 39, 119-177. https://doi.org/10.1093/eurheartj/ehx393 |
[4] | Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., et al. (2020) Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy. Thrombosis Research, 191, 9-14. https://doi.org/10.1016/j.thromres.2020.04.024 |
[5] | Gorenek, B., Blomström Lundqvist, C., Brugada Terradellas, J., Camm, A.J., Hindricks, G., Huber, K., et al. (2015) Cardiac Arrhythmias in Acute Coronary Syndromes: Position Paper from the Joint EHRA, ACCA, and EAPCI Task Force. EuroIntervention, 10, 1095-1108. https://doi.org/10.4244/eijy14m08_19 |
[6] | Bahit, M.C., Kochar, A. and Granger, C.B. (2018) Post-Myocardial Infarction Heart Failure. JACC: Heart Failure, 6, 179-186. https://doi.org/10.1016/j.jchf.2017.09.015 |
[7] | Xiang, D., Xiang, X., Zhang, W., Yi, S., Zhang, J., Gu, X., et al. (2020) Management and Outcomes of Patients with STEMI during the COVID-19 Pandemic in China. Journal of the American College of Cardiology, 76, 1318-1324. https://doi.org/10.1016/j.jacc.2020.06.039 |
[8] | Rodriguez-Leor, O., Cid-Alvarez, B., Ojeda, S., Martin-Moreiras, J., Rumoroso, J.R., et al. (2020) Impact of the COVID-19 Pandemic on Interventional Cardiology Activity in Spain. REC: Inteventional Cardiology, 2, 82-89. |
[9] | Tam, C.F., Cheung, K., Lam, S., Wong, A., Yung, A., Sze, M., et al. (2020) Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circulation: Cardiovascular Quality and Outcomes, 13, e006631. https://doi.org/10.1161/circoutcomes.120.006631 |
[10] | Thakker, R.A., Elbadawi, A., Chatila, K.F., Goel, S.S., Reynoso, D., Berbarie, R.F., et al. (2022) Comparison of Coronary Artery Involvement and Mortality in STEMI Patients with and without SARS-CoV-2 during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Current Problems in Cardiology, 47, Article 101032. https://doi.org/10.1016/j.cpcardiol.2021.101032 |
[11] | Giustino, G., Pinney, S.P., Lala, A., Reddy, V.Y., Johnston-Cox, H.A., Mechanick, J.I., et al. (2020) Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia. Journal of the American College of Cardiology, 76, 2011-2023. https://doi.org/10.1016/j.jacc.2020.08.059 |
[12] | De Rosa, S., Spaccarotella, C., Basso, C., Calabrò, M.P., Curcio, A., Filardi, P.P., et al. (2020) Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era. European Heart Journal, 41, 2083-2088. https://doi.org/10.1093/eurheartj/ehaa409 |
[13] | Wu, J., Mamas, M., Rashid, M., Weston, C., Hains, J., Luescher, T., et al. (2020) Patient Response, Treatments, and Mortality for Acute Myocardial Infarction during the COVID-19 Pandemic. European Heart Journal—Quality of Care and Clinical Outcomes, 7, 238-246. https://doi.org/10.1093/ehjqcco/qcaa062 |